Browse All

Current Filters

CLEAR FILTER x

TITLE

Real-world Effectiveness, Tolerability, and Safety of Ofatumumab at 12-month Follow-up

Author:Hersh, Carrie   Amin, Moein   Harvey, Tucker   Moss, Brandon   Tai, Ming-Hui   Gadkari, Abhijit   Brown, Brandon   Conway, Devon   

Session Name:P9: Multiple Sclerosis: Clinical Trials and Therapeutics (including Safety) 2  

Topic:Multiple Sclerosis  

Program Number:P9.014  

Author Institution:Lou Ruvo Center for Brain Health, Cleveland Clinic, Las Vegas, NV  Mellen Center for MS Treatment and Research, Cleveland Clinic, Cleveland, OH  Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH  Novartis Pharmaceuticals Corporation, East Hanover, NJ